Immunosuppressive properties of human PD-1+ PDL-1+ dendritic cell from Lymph Nodes Aspirates of NSCLC patients.
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), R. Sokolowski (Warsaw, Poland), J. Bednarek (Warsaw, Poland), A. Raniszewska (Warsaw, Poland), K. Jahnz-Rózyk (Warsaw, Poland), P. Rzeepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland)
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Session: Molecular alterations and immunology in lung cancer
Session type: E-poster session
Number: 1656
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), R. Sokolowski (Warsaw, Poland), J. Bednarek (Warsaw, Poland), A. Raniszewska (Warsaw, Poland), K. Jahnz-Rózyk (Warsaw, Poland), P. Rzeepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland). Immunosuppressive properties of human PD-1+ PDL-1+ dendritic cell from Lymph Nodes Aspirates of NSCLC patients.. 1656
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: